Introduction
Tenofovir is a nucleotide reverse transcription inhibitor. It is widely
used for the treatment of HIV and Hepatitis B. The most common side
effect of the drug is gastrointestinal which is usually
mild.1,2 Other side effects include hepatic,
nephrological, pancreatitis, Fanconi’s anemia, diabetes insipidus, and
pneumonia.2,3 The incidence of cutaneous adverse
effects ranges from 5% to 18%. However, they have not been well
documented.4,5 Tenofovir is the least suspected drug
for cutaneous side effects as there are many other anti-viral
medications used for the treatment of HIV with well-documented adverse
effects. Only two cases of Leukocytoclastic vasculitis due to tenofovir
have been reported to date. Here, we present a third case and also
review the cutaneous side effects of tenofovir.